Explore life science & biotech companies in Oxford, home to one of the world's leading biotechnology and life science clusters.
AI-powered medical imaging software for stroke, oncology and lung disease
Brainomix is a UK software company specialising in AI-powered imaging biomarkers and Software as a Medical Device (SaMD) to support clinical decision-making in stroke, lung fibrosis, and cancer. Its platform provides clinicians with automated imaging analysis to guide treatment decisions in acute stroke care and is…
Immunological reagents, assay services and target-binding proteins for immune research
ProImmune is a provider of immunological reagents and assay services supporting research into adaptive immune responses. The company offers assay services to help researchers understand immune responses to vaccines and therapeutics, using ELISpot and flow cytometry techniques, alongside recombinant target-binding…
Synthetic T cell-priming vaccines and immunotherapies for infectious disease
Gylden Pharma is a clinical-stage biotechnology company developing 100% synthetic T cell-priming vaccines and immunotherapies. Its nanoparticle platform delivers synthetic peptides that stimulate cellular immune responses against intracellular pathogens, providing strain-agnostic protection without cold-chain…
High-capacity viral vector manufacturing platform for gene therapy
Icosphere Biosciences is a biotechnology company developing manufacturing technology for high-capacity gene therapy vectors. Its platform enables scalable, high-yield, contamination-free production of high capacity adenoviral vectors capable of carrying substantially more genetic material than conventional viral…
Intra-uterine sensor platform for continuous uterine biomarker monitoring
Verso Biosense is a femtech medtech company developing a miniaturised intra-uterine sensor device for continuous physiological monitoring of the uterus. The battery-free implantable device measures temperature, dissolved oxygen, and pH in real time, transmitting data wirelessly to a proprietary software platform.…
AI-powered rapid pathogen ID and antibiotic susceptibility from blood
Vivid Dx is a University of Oxford spin-out developing a culture-free diagnostics platform for rapid pathogen identification and antimicrobial susceptibility testing directly from blood samples. The system combines Raman spectroscopy, microfluidics, and deep learning to deliver species-level pathogen identification in…
AI-powered digital pathology laboratory services for rapid cancer diagnosis
Inify Laboratories is a digital pathology company providing cancer diagnostic services through a fully digital, AI-supported laboratory workflow. The company processes tissue biopsy samples, generating whole slide images that are analysed by its proprietary AI software before review and reporting by specialist…
The UK's largest single-ownership science and technology park near Oxford
Milton Park is the UK's largest single-ownership science, business and technology park, located in South Oxfordshire between Abingdon and Didcot. Spanning 300 acres with nearly three million square feet of floor space, it hosts over 270 organisations across life sciences, energy, space and supporting technologies, and…
Injectable biomaterial gel to treat degenerative disc disease
Orthoson is a medtech company developing micro-invasive injectable treatments for chronic back pain caused by degenerative disc disease. Its lead product, a patented pNIPAM-DMAc co-polymer hydrogel, is designed to be injected into the intervertebral disc, where it gels in-situ to restore the mechanical and biological…
Oncolytic virus immunotherapies engineered to destroy solid tumours
Bioarchitech is a preclinical-stage biotechnology company developing oncolytic virus-based immunotherapies for the treatment of common solid tumours. The company engineers vaccinia virus to encode antibody-like immunotherapy molecules within the viral genome, enabling localised delivery of immune-activating payloads…
Antigen modulation therapies for cancer and autoimmune disease
Grey Wolf Therapeutics is a clinical-stage biotechnology company developing small molecule inhibitors of endoplasmic reticulum aminopeptidases (ERAP1 and ERAP2) to modulate antigen presentation on cell surfaces. In oncology, this approach enhances tumour visibility to the immune system; in autoimmunity, it aims to…
AI-powered software for large-scale microscopy and scientific data
Dataflight Solutions is a scientific software company developing infrastructure for processing, visualising and analysing large biological datasets. Its technology focuses on high-volume three-dimensional fluorescence microscopy, using adaptive data representations to reduce storage and computation requirements. The…
Spider-inspired protein fibre spinning for sustainable and biocompatible materials
Spintex Engineering is a developer of bioinspired silk fibres, produced from a liquid protein feedstock using a spider-inspired self-assembly process. The technology requires no hazardous chemicals, with water as the only by-product, and is significantly more energy efficient than synthetic fibre production. Spintex's…
Portable PCR diagnostic platforms and test kits for veterinary use
ZYTCA Animal Health is a veterinary diagnostics company developing portable point-of-care PCR platforms for rapid disease detection in animals. Using isothermal amplification and lateral flow immunoassay technology, its devices deliver qualitative results in under 30 minutes from unextracted clinical samples, with a…
AI-ready toxicity datasets for preclinical drug discovery
Biolligence is a biotechnology company developing AI-ready toxicity datasets and predictive tools for the drug discovery industry. The company combines deep learning algorithms with stem cell-derived in vitro models and clinical data to generate mechanistic toxicity information aimed at reducing dependence on animal…
Genomic risk prediction platform for preventive healthcare and drug discovery
Genomics is a data science company that uses large-scale human genetic data to power precision healthcare and drug discovery. Its proprietary platform links millions of genetic variants to thousands of biological measurements and disease outcomes, generating polygenic risk scores that enable earlier identification of…
Inorganic nanoscale immune modulators for infection, cancer and autoimmunity
Iuvantium is a biotechnology company developing therapeutics and vaccines based on inorganic nanoscale materials that modulate the immune system. The company uses tailored inorganic probes to study how the immune system responds, builds a computational model of immune behaviour, and designs programmable immune…
AI echocardiography platform for heart failure detection
Ultromics is an Oxford University spin-out developing AI-powered software that analyses routine echocardiogram images to detect complex cardiac conditions. Its cloud-based platform holds multiple FDA clearances and CE marks for heart failure with preserved ejection fraction and cardiac amyloidosis screening. The…
Novel mode-of-action herbicide discovery platform
Moa Technology discovers synthetic and biological herbicides with novel modes of action to address herbicide resistance. Its high-throughput platform uses miniaturised living plants, high-content microscopy and AI to identify new compounds. The company has screened more than 900,000 compounds and identified over 80…
Hydrogel capsule platform for weight loss and oral drug delivery
Oxford Medical Products is developing a gastroretentive hydrogel platform with two applications. The technology is a swallowable dual-polymer capsule that expands in the stomach to suppress appetite without pharmacological intervention; a Phase 2a clinical trial is underway following positive Phase 1 results. Oxford…